Distinguished Faculty
Co-Chairs
Uttam Dhillon
Chair, Regulatory Defense, Compliance & White-Collar Practice Group
Michael Best & Friedrich LLP
(Former Chief Counsel, U.S. Drug Enforcement Administration)
Dayle Elieson
Principal
Dayle Elieson PLLC
(Former Chief Counsel, U.S. Drug Enforcement Administration)
Keynote Speakers
Eric Triana
Deputy Assistant Administrator
DEA Office of Diversion Control Operations
Amanda Liskamm
Principal Deputy Director, Consumer Protection Branch
U.S. Department of Justice
Dominic Chiapperino, Ph.D.
Director, Controlled Substances Staff
U.S. Food and Drug Administration
Government
Scott B. Dahlquist
Trial Attorney, Consumer Protection Branch
U.S. Department of Justice
Dwayne Jeffcoat
DEA Diversion Investigator
U.S. Drug Enforcement Administration
Elliot M. Schachner
Assistant U.S. Attorney
U.S. Attorney’s Office Eastern District of New York
In-House Leadership, In-House Counsel, Consultants, and Law Firms
Nathan Beaver
Partner
Foley and Lardner LLP
Michele Buenafe
Partner
Morgan, Lewis & Bockius LLP
Charrai Byrd, PharmD
Pharmacy Operations Manager - Controlled Substances
New York-Presbyterian Hospital
Ronald Chapman II
Owner
Chapman Law Firm
Roger Cohen
Life Sciences Partner
Goodwin Procter LLP
Shannon Cox
Counsel
King & Spalding LLP
Hunter G. DeKoninck
Practice Group Attorney
Quarles & Brady LLP
Tom Firestone
Partner
Stroock & Stroock & Lavan LLP
Todd A. Harrison
Partner
Venable LLP
Derrelle M. Janey
Managing Partner
The Janey Law Firm PC
Michael Labson
Partner
Covington & Burling LLP
Seth A. Mailhot
Partner
Husch Blackwell LLP
Andrew O’Connor
Partner
Ropes & Gray LLP
Karla L. Palmer
Director
Hyman, Phelps & McNamara PC
Jason Parish
Shareholder
Buchanan Ingersoll & Rooney PC
Joseph Shepherd
Global Senior Director, Controlled Substances Leader
The Janssen Pharmaceutical Companies of Johnson & Johnson
Jack Teitelman
Founder & CEO
TITAN Group
